NRP1 and central nervous system cancer: Aimed at targeting specifically glioma cells, liposomes functionalized with R6dGR peptide (R6dGR-Lip), that is able to recognize integrin receptors ανβ3 and neuropilin-1 (NRP1), a membrane-bound co-receptor of tyrosine kinase receptor, were developed (Wang et al., 2018).